Chuck Broes, CEO of Quantum Immunologics, discusses the company's groundbreaking find in cancer research and treatment arenas. Josh Coughlin, President of QI, gives an overview of business strategies and goals.
Tags: quantum immunologics josh coughlin chuck broes cancer research cancer treatment
Peregrine Pharmaceuticals CEO Steven King talks to onemedplace about recent developments in the company.
Dr. Raafat Fahim Ph.D., Chief Executive Officer of Nabi Biopharmaceuticals talks about recent developments in the company. Nabi Biopharmaceuticals Develops first and second generation products to treat nicotine addiction and gram-positive bacterial infections.
Tags: Chief Executive Officer
DATATRAK International, Inc. is a technology and services company focused on global eclinical solutions for the clinical trials industry. Laurence Birch talks to onemedplace about the company and their recent developments.
CEO Joseph Kim talks about recent developments with Inovio Biomedical. Inovio designs, develops, and delives a new generation of vaccines focused on cancers and infectious diseases.
Tags: Inovio Biomedical onemedplace joseph kim vaccine vaccination cancer infectious disease
neopharm is engaged in the research, development and commercialization of new drugs for various cancers, other diseases, and therapeutic applications. The company's drug development program includes two proprietary platforms: the tumor-targeting toxin platform and the neolipid drug delivery system.
Tags: lung fibrosis drug pipeline cancer neolipid drug delivery tumor targeting stem cell NEOL
Jeffrey Davis talks about recent developments with Access Pharmaceuticals. Access develops and commercializes propriety products for the treatment and care of cancer patients.
Tags: Access Pharmaceuticals jeffrey davis cancer treatment onemedplace
Cytori Therapeutics CEO Christopher Calhoun discusses his firm's research in regenerative medicine.
Tags: cytori therapeutics christopher calhoun regenerative medicine onemedplace
